Evaluation of medication and herbal product use among pregnant women

Basit Öğe Kaydı
dc.authorid0000-0001-8902-7274
dc.authorid0000-0003-3188-4278
dc.authorid0000-0003-0223-2959
dc.contributor.authorUmar, Rashida Muhammad
dc.contributor.authorBeşiroğlu, Rabia
dc.contributor.authorŞahin, Ayşe Kevser
dc.contributor.authorKarataş Koçberber, Emine
dc.contributor.authorCeylan, Cengizhan
dc.date.accessioned2021-11-05T08:11:17Z
dc.date.available2021-11-05T08:11:17Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalı
dc.description.abstractThe use of medications and herbal products among women increases after pregnancy. The purpose of the study is to evaluate the frequency of medication used and analyzed them based on the FDA pregnancy risk categories. This cross-sectional study was conducted on 300 adult volunteers attending antenatal care in a university-affiliated hospital. Medications were classified according to the FDA pregnancy risk classification. In 97,7% of women, the use of at least one medication during pregnancy. The median count for Category A medications was 2. Category C and B medications were reported by 100 (33,3%) and 53 women (17,7%). There was a significant difference between the education level and the use of herbal products (p=0.043). Pharmacists should take a greater role in educating pregnant women and women of childbearing age about the possible consequences of medications on the development of the fetus and guide healthcare practitioners in choosing the most appropriate medications.
dc.identifier.citationUmar, R. M., Beşiroğlu, R., Şahin, A. K., Karataş Koçberber, E. ve Ceylan, C. (2021). Evaluation of medication and herbal product use among pregnant women. Acta Pharmaceutica Sciencia, 59(4), 575-588. https://dx.doi.org/10.23893/1307-2080.APS.05936
dc.identifier.doi10.23893/1307-2080.APS.05936
dc.identifier.endpage588
dc.identifier.issn1307-2080
dc.identifier.issue4
dc.identifier.scopusqualityQ3
dc.identifier.startpage575
dc.identifier.urihttps://dx.doi.org/10.23893/1307-2080.APS.05936
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8570
dc.identifier.volume59
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherIstanbul Medipol University
dc.relation.ispartofActa Pharmaceutica Scienciaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFDA Risk Category
dc.subjectHerbal Product Use
dc.subjectMedication Use
dc.subjectPregnancy
dc.titleEvaluation of medication and herbal product use among pregnant women
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Umar-Rashida-2021.pdf
Boyut:
521.81 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Eczacılık Fakültesi Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu